Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP828307.RATDsYAlqMBrYY5EXp5hVrqK5NJAsmxRFTvydWSlki4sE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP828307.RATDsYAlqMBrYY5EXp5hVrqK5NJAsmxRFTvydWSlki4sE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP828307.RATDsYAlqMBrYY5EXp5hVrqK5NJAsmxRFTvydWSlki4sE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP828307.RATDsYAlqMBrYY5EXp5hVrqK5NJAsmxRFTvydWSlki4sE130_provenance.
- NP828307.RATDsYAlqMBrYY5EXp5hVrqK5NJAsmxRFTvydWSlki4sE130_assertion description "[Eight patients, five with pituitary carcinomas (three prolactin (PRL) and two ACTH) and three with aggressive pituitary tumors (one PRL and two ACTH), all treated with temozolomide administered orally for four to 24 cycles, were included in our French multicenter study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP828307.RATDsYAlqMBrYY5EXp5hVrqK5NJAsmxRFTvydWSlki4sE130_provenance.
- NP828307.RATDsYAlqMBrYY5EXp5hVrqK5NJAsmxRFTvydWSlki4sE130_assertion evidence source_evidence_literature NP828307.RATDsYAlqMBrYY5EXp5hVrqK5NJAsmxRFTvydWSlki4sE130_provenance.
- NP828307.RATDsYAlqMBrYY5EXp5hVrqK5NJAsmxRFTvydWSlki4sE130_assertion SIO_000772 20660056 NP828307.RATDsYAlqMBrYY5EXp5hVrqK5NJAsmxRFTvydWSlki4sE130_provenance.
- NP828307.RATDsYAlqMBrYY5EXp5hVrqK5NJAsmxRFTvydWSlki4sE130_assertion wasDerivedFrom befree-2016 NP828307.RATDsYAlqMBrYY5EXp5hVrqK5NJAsmxRFTvydWSlki4sE130_provenance.
- NP828307.RATDsYAlqMBrYY5EXp5hVrqK5NJAsmxRFTvydWSlki4sE130_assertion wasGeneratedBy ECO_0000203 NP828307.RATDsYAlqMBrYY5EXp5hVrqK5NJAsmxRFTvydWSlki4sE130_provenance.
- befree-2016 importedOn "2016-02-19" NP828307.RATDsYAlqMBrYY5EXp5hVrqK5NJAsmxRFTvydWSlki4sE130_provenance.